News Articles
Latest articles, insights, and updates from the blog.
Contact Low Dose Ketamine
Send corrections, provider questions, or advertising inquiries.
ECT, TMS, and Esketamine: Mapping Options for TRD
A new Psychiatric Times review compares ECT, TMS, and esketamine for treatment-resistant depression. Here's how off-label low-dose ketamine fits in.
After Two Failed Antidepressants: TMS and Esketamine
A KevinMD commentary urges faster escalation to TMS and esketamine after two failed antidepressants. Here's what that means for ketamine therapy patients.
Ketamine's Effects on Older Adults' Brain Activity Studied
Futurity reported new research on how ketamine affects brain activity in older adults. Here's what's confirmed, what's unclear, and what to ask your clinician.
New Study Finds Ketamine Eases Resistant Bipolar Depression
A new report describes ketamine reducing treatment-resistant bipolar depression symptoms safely. Here is what the evidence shows and what remains unclear.
Inside a Ketamine Trial: One Patient's Infusion Account
A clinical trial participant describes a ketamine infusion, per a September 2026 report. Here's what the account reveals and what remains unverified.
New Prescriber's Guide Details Oral Ketamine Protocol
A new clinical guide outlines dosing principles and monitoring for oral ketamine in major depressive illness. Here's what it means for patients and prescribers.
Ketamine's Neuroplasticity Boost Isn't Universal
New research indicates ketamine's neuroplasticity effects vary between individuals, raising questions for low-dose treatment expectations and monitoring.
Veterans, First Responders Discuss Ketamine Therapy
A Callahan County, Texas report features veterans and first responders discussing ketamine-assisted therapy for PTSD. Here's what the evidence actually shows.
When Antidepressants Fail: What Comes Next for TRD?
STAT reports on treatment-resistant depression care after oral antidepressants fail; here's how ketamine therapy fits into next-step options.
UT Health San Antonio Adds Ketamine to Amputee Care
UT Health San Antonio's Limb Optimization Program is using ketamine therapy alongside multidisciplinary amputee care. Here's what the evidence says.
FDA Targets Illegal Ketamine Sellers in 2026 Crackdown
The FDA is targeting illegal ketamine sellers as the psychedelic revolution nears. What this enforcement shift means for patients in legitimate low-dose care.
Treatment-Resistant Depression: Recovery Is Possible
WebMD covers recovery from treatment-resistant depression. Here's what TRD recovery looks like and where low-dose ketamine fits into the treatment picture.
FDA Clears NRX-101 + TMS Combo for Severe Depression
The FDA has authorized NRx Pharmaceuticals to offer NRX-101 combined with TMS for severe depression, here's what it means for the ketamine treatment landscape.